Abstract | BACKGROUND: Epidemiological observations have demonstrated that ambient fine particulate matter with dp < 2.5 μm (PM2.5) as the major factor responsible for the increasing incidence of lung cancer in never-smokers. However, there are very limited experimental data to support the association of PM2.5 with lung carcinogenesis and to compare PM2.5 with smoking carcinogens. METHODS: To study whether PM2.5 can contribute to lung tumorigenesis in a way similar to smoking carcinogen 4-methylnitrosamino-l-3-pyridyl-butanone (NNK) via 15-lipoxygenases (15-LOXs) reduction, normal lung epithelial cells and cancer cells were treated with NNK or PM2.5 and then epigenetically and post-translationally examined the cellular and molecular profiles of the cells. The data were verified in lung cancer samples and a mouse lung tumor model. RESULTS: We found that similar to smoking carcinogen NNK, PM2.5 significantly enhanced cell proliferation, migration and invasion, but reduced the levels of 15-lipoxygenases-1 (15-LOX1) and 15-lipoxygenases-2 (15-LOX2), both of which were also obviously decreased in lung cancer tissues. 15-LOX1/15-LOX2 overexpression inhibited the oncogenic cell functions induced by PM2.5/NNK. The tumor formation and growth were significantly higher/faster in mice implanted with PM2.5- or NNK-treated NCI-H23 cells, accompanied with a reduction of 15-LOX1/15-LOX2. Moreover, 15-LOX1 expression was epigenetically regulated at methylation level by PM2.5/NNK, while both 15-LOX1 and 15-LOX2 could be significantly inhibited by a set of PM2.5/NNK-mediated microRNAs. CONCLUSION: Collectively, PM2.5 can function as the smoking carcinogen NNK to induce lung tumorigenesis by inhibiting 15-LOX1/15-LOX2.
|
Authors | Ming-Yue Li, Li-Zhong Liu, Wende Li, Calvin S H Ng, Yi Liu, Angel W Y Kong, Zhili Zhao, Shanshan Wang, Haolong Qi, Hao Jia, Shucai Yang, Jing Du, Xiang Long, Rocky L K Ho, Ernest C W Chak, Innes Y P Wan, Tony S K Mok, Malcolm J Underwood, Nirmal Kumar Gali, Zhi Ning, George G Chen |
Journal | Journal of experimental & clinical cancer research : CR
(J Exp Clin Cancer Res)
Vol. 38
Issue 1
Pg. 359
(Aug 16 2019)
ISSN: 1756-9966 [Electronic] England |
PMID | 31420013
(Publication Type: Journal Article)
|
Chemical References |
- Biomarkers, Tumor
- Lipoxygenase Inhibitors
- Nitrosamines
- Particulate Matter
- ALOX15B protein, human
- Arachidonate 15-Lipoxygenase
|
Topics |
- Animals
- Apoptosis
- Arachidonate 15-Lipoxygenase
(chemistry)
- Biomarkers, Tumor
(metabolism)
- Carcinogenesis
(chemically induced, metabolism, pathology)
- Case-Control Studies
- Cell Movement
- Cell Proliferation
- Female
- Gene Expression Regulation, Neoplastic
- Humans
- Lipoxygenase Inhibitors
(adverse effects)
- Lung Neoplasms
(enzymology, etiology, pathology)
- Mice
- Mice, Inbred BALB C
- Mice, Nude
- Nitrosamines
(toxicity)
- Particulate Matter
(adverse effects)
- Prognosis
- Smoking
(adverse effects)
- Tumor Cells, Cultured
- Xenograft Model Antitumor Assays
|